Viewing Study NCT02857920


Ignite Creation Date: 2025-12-25 @ 4:08 AM
Ignite Modification Date: 2025-12-26 @ 3:05 AM
Study NCT ID: NCT02857920
Status: COMPLETED
Last Update Posted: 2020-09-14
First Post: 2016-08-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
Sponsor: Fuda Cancer Hospital, Guangzhou
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module